Treating OCD during COVID-19: Pharmacotherapy and combined treatments

 

Presented by Stephanie C. Eken, MD, FAAP, and Joshua Nadeau, PhD

View slides from this presentation

This presentation will provide a review of empirically supported pharmacological interventions for OCD and address some of the unique challenges of delivering this treatment both alone and in combination with CBT via telepsychiatry. 

Related resources

#
Treating anxious and depressed youth with ASD during COVID-19
In this webinar, learn about the unique challenges facing youth with autism…
Learn more
#
Treating co-occurring mental health and addiction during COVID-19: Cultural and community factors
Part two of this series will highlight important cultural considerations…
Learn more
#
Treating co-occurring mental health and addiction during COVID-19: Considerations for telehealth
In part one of this webinar series, learn about the factors that must be…
Learn more

Call 800-767-4411 or go to rogersbh.org to request a free screening.